mrs

MRS 1754 is a selective antagonist radioligand for the A2B adenosine receptor, exhibiting very low affinity for A1 and A3 receptors in both humans and rats.

MRS-3777 hemioxalate, a selective adenosine A3 receptor antagonist, reverses the anti-injury perception effects of its corresponding agonist and serves as a valuable tool for studying inflammatory pain.

MRS1845 is an ORAI1 inhibitor and calcium entry (SOCE) blocker that blocks VP-induced SOCE, OS, and Ca(2+) deposition.

MRS-1191 is an effective and selective A3 adenosine receptor antagonist (KB: 92 nM, a Ki: 31.4 nM for human A3 receptor and an IC50: 120 nM for CHO cells).

MRS 1523 can exert an antihyperalgesic effect through N-type Ca channel block and action potential inhibition in isolated rat dorsal root ganglion (DRG) neurons. MRS 1523 is an effective and selective adenosine A3 receptor antagonist Ki: 18.9 nM and 113 n

MRS1177 is an effective and selective antagonist of the human Adenosine A3 receptor (hA3AR) (Ki: 0.3 nM).

MRS1186 is an effective and selective antagonist of the human Adenosine A3 receptor (Ki: 7.66 nM).

MRS1220, a selective and potent antagonist for the human A3 adenosine receptor (hA3AR) with a dissociation constant (Ki) of 0.59 nM, exhibits therapeutic promise for central nervous system disease research. It effectively diminishes glioblastoma tumor size and inhibits blood vessel formation in vivo.

antagonist for the human adenosine A3 receptor

competitive antagonist at P2Y1 receptors

P2Y13 receptor antagonist

Selective, high affinity competitive antagonist of the P2Y1 receptor

Highly potent, selective P2Y1 receptor agonist

Highly potent and selective antagonist of the platelet P2Y1 receptor

MRS 2693 trisodium salt is a P2Y6 agonist.

MRS2500 is a highly potent and selective platelet P2Y1 receptor antagonist.

MRS4458 is an effective inhibitor of the P2Y14 Receptor.

MRS4478 is an effective inhibitor of the P2Y14 Receptor.

MRS-1477 is used as a TRPV1 positive allosteric modulator (PAM).

MRS2298, a potent antagonists of the P2Y 1 receptor, has antiaggregatory activity in human platelets.

MRS2802 is a P2Y14 receptor agonist, its EC50 value for P2Y14 receptor is 63 nM.

MRS3558 is an agonist of A3 adenosine receptors.

MRS5698 is a high affinity and selective agonist of A3 adenosine receptor (Ki ~ 3 nM) protects against chronic neuropathic pain. MRS5698 displays >1000-fold selectivity over A1 and A2A adenosine receptors

MRS1041 is a bioactive chemical.